Neogen Corporation (NASDAQ: NEOG) is a Healthcare company (Medical - Devices) with a market capitalization of $2.4B. The Maz Rating grades it against the other companies in its sector.
Neogen Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $10.91, Neogen Corporation trades at 2.7x sales and 1.1x book value, with an EV/EBITDA of 28.3. Over the last twelve months it generated about $887M of revenue and a net loss of $55M. It runs a gross margin of 47.4%, an operating margin of -0.8% and a net margin of -6.3%. It shows return on equity of -2.7%, return on invested capital of -0.2% and a free cash flow yield of 2.1%. On the balance sheet: a debt-to-equity ratio of 0.37 and a current ratio of 3.90. Over the past 52 weeks the share price ranged from $5.37 to $14.26, with a beta of 1.86.
Neogen Corporation does not currently pay a dividend.
11 Wall Street analyst ratings cover the stock: 5 Buy, 5 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
Yes. As of August 2026, Neogen Corporation (NEOG) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 29.4% / 30% · (Cash+Inv) / Mkt Cap (36m) 6.53% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 29.4% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 6.53% / 33% · Receivables / Mkt Cap (36m) 5.17% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 29.4% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 6.53% / 33.33% · Receivables / Mkt Cap (24m) 5.17% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 23.6% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 4.96% / 33.33% · Receivables / Avg Assets (4Q) 4.13% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| FTSE | Debt / Total Assets 23.4% / 33.33% · (Cash+ST Inv) / Total Assets 5.21% / 33.33% · (Cash+Recv) / Total Assets 9.33% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
Yes. As of August 2026, Neogen Corporation (NEOG) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
Yes. Neogen Corporation is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
Neogen Corporation reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated August 31, 2026 (Q1 2027). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.